Introducing ALZET?ew Model 2006 Pump  Sign up for PNAS Online eTocs
Link: Info for AuthorsLink: Editorial BoardLink: AboutLink: SubscribeLink: AdvertiseLink: ContactLink: Sitemap Link: PNAS Home
Proceedings of the National Academy of Sciences
Link: Current Issue "" Link: Archives "" Link: Online Submission ""  Link: Advanced Search

Published online on July 3, 2007, 10.1073/pnas.0705041104
PNAS | July 10, 2007 | vol. 104 | no. 28 | 11766-11771


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supporting Information
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Desai, U.
Right arrow Articles by Powell, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Desai, U.
Right arrow Articles by Powell, D. R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg  
What's this?

 Previous Article  | Table of Contents |  Next Article 

BIOLOGICAL SCIENCES / MEDICAL SCIENCES
Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice

Urvi Desai*, E-Chiang Lee{dagger}, Kyu Chung{dagger},{ddagger}, Cuihua Gao{dagger}, Jason Gay*, Billie Key{dagger}, Gwenn Hansen§, Dennis Machajewski{dagger}, Kenneth A. Platt§, Arthur T. Sands*,{dagger},§, Matthias Schneider*, Isaac Van Sligtenhorst*, Adisak Suwanichkul§, Peter Vogel*, Nat Wilganowski*, June Wingert*, Brian P. Zambrowicz*,{dagger},§, Greg Landes{dagger}, and David R. Powell*

Departments of *Pharmaceutical Biology, {dagger}Biotherapeutics, and §Genetics, Lexicon Pharmaceuticals, Inc., 8800 Technology Forest Place, The Woodlands, TX, 77381

Communicated by C. Thomas Caskey, University of Texas-Houston Health Science Center, Houston, TX, May 30, 2007 (received for review March 13, 2007)

We used gene knockout mice to explore the role of Angiopoietin-like-4 (Angptl4) in lipid metabolism as well as to generate anti-Angptl4 mAbs with pharmacological activity. Angptl4 –/– mice had lower triglyceride (TG) levels resulting both from increased very low-density lipoprotein (VLDL) clearance and decreased VLDL production and had modestly lower cholesterol levels. Also, both Angptl4 –/– suckling mice and adult mice fed a high-fat diet showed reduced viability associated with lipogranulomatous lesions of the intestines and their draining lymphatics and mesenteric lymph nodes. Treating C57BL/6J, ApoE –/–, LDLr –/–, and db/db mice with the anti-Angptl4 mAb 14D12 recapitulated the lipid and histopathologic phenotypes noted in Angptl4 –/– mice. This demonstrates that the knockout phenotype reflects not only the physiologic function of the Angptl4 gene but also predicts the pharmacologic consequences of Angptl4 protein inhibition with a neutralizing antibody in relevant models of human disease.

monoclonal antibody | mouse | triglycerides | cholesterol


Author contributions: U.D. and E-C.L. contributed equally to the work; U.D., E-C.L., A.T.S., B.P.Z., G.L., and D.R.P. designed research; K.C., C.G., J.G., B.K., D.M., M.S., I.V.S., N.W., and J.W. performed research; G.H., K.A.P., and A.S. contributed new reagents/analytic tools; U.D., P.V., and D.R.P. analyzed data; and U.D., E-C.L., G.L., and D.R.P. wrote the paper.

{ddagger}Present address: Agdia Incorporated, Elkhart, IN 46514.

Conflict of interest statement: All authors are or have been employed by Lexicon Pharmaceuticals, Inc., and may own publicly traded stock in Lexicon. The research was supported by Lexicon.

This article contains supporting information online at www.pnas.org/cgi/content/full/0705041104/DC1.

To whom correspondence should be addressed. E-mail: dpowell{at}lexpharma.com

© 2007 by The National Academy of Sciences of the USA


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg    What's this?